Biogen Inc.

07/26/2021 | Press release | Distributed by Public on 07/26/2021 08:04

Reduction in Biomarkers of Alzheimer’s Disease Pathophysiology Following Treatment with Aducanumab Were Associated with Slowing Clinical Decline